Mark E. Saad

Insider Reports History

Location
San Diego, CA
Signature
/s/ Nick Pizzie, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark E. Saad:

Company Role Class Num Shares Value Price $ Report Date Ownership
Axsome Therapeutics, Inc. Director Common Stock 10,002 $1,652,130 $165.18 31 Dec 2025 Direct
Axsome Therapeutics, Inc. Director Common Stock 300 $43,566 $145.22 31 Dec 2025 Indirect
Axsome Therapeutics, Inc. Director Stock Option (Right to Buy) 0 $5,229 $3.50 31 Dec 2025 Direct
Axsome Therapeutics, Inc. Director Restricted Stock Units 1,429 06 Jun 2025 Direct

Insider Reports Filed by Mark E. Saad

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AXSM Axsome Therapeutics, Inc. 31 Dec 2025 6 -$6,001,834 4 Director 02 Jan 2026, 19:02
AXSM Axsome Therapeutics, Inc. 05 Sep 2025 3 -$1,059,371 4 Director 05 Sep 2025, 19:43
AXSM Axsome Therapeutics, Inc. 06 Jun 2025 2 $0 4 Director 10 Jun 2025, 19:00
AXSM Axsome Therapeutics, Inc. 21 Feb 2025 1 $0 4 Director 25 Feb 2025, 19:59
AXSM Axsome Therapeutics, Inc. 11 Sep 2024 3 -$965,442 4 Director 11 Sep 2024, 19:00
AXSM Axsome Therapeutics, Inc. 07 Jun 2024 1 $0 4 Director 11 Jun 2024, 16:30
AXSM Axsome Therapeutics, Inc. 27 Feb 2024 1 $0 4 Director 29 Feb 2024, 18:34
AXSM Axsome Therapeutics, Inc. 02 Jun 2023 1 $0 4 Director 06 Jun 2023, 18:22
AXSM Axsome Therapeutics, Inc. 02 Mar 2023 1 $0 4 Director 06 Mar 2023, 17:12
AXSM Axsome Therapeutics, Inc. 03 Jun 2022 1 $0 4 Director 07 Jun 2022, 16:08
AXSM Axsome Therapeutics, Inc. 04 Mar 2022 1 $0 4 Director 08 Mar 2022, 16:00
AXSM Axsome Therapeutics, Inc. 17 Nov 2021 4 +$113,922 4 Director 19 Nov 2021, 06:30
AXSM Axsome Therapeutics, Inc. 04 Jun 2021 1 $0 4 Director 08 Jun 2021, 16:52